Pharmaceuticals

LATEST

Bayer CEO: I don't feel the need to join M&A fever

Merge lanes road sign

Bayer CEO Marijn Dekkers told CNBC he did not feel a need to make acquisitions, as U.S. pharmaceutical giant Pfizer confirmed it had make a second bid approach toAstraZeneca , potentially creating a $100 billion-plus merger.

Merck to slash jobs, cut expenses by $2.5 billion

Departure

Pharmaceutical giant Merck announced plans on Tuesday to slash an additional 8,500 jobs on top of previously announced job cuts, adding that it planned to cut operating expenses by $2.5 billion by the end of 2015.

HOT LIST

FEATURED